Genmab A/S (GMAB)
34.69
-0.05
(-0.14%)
USD |
NASDAQ |
Sep 21, 16:00
34.68
-0.01
(-0.03%)
After-Hours: 20:00
Genmab EPS Diluted (TTM) : 1.263 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.263 |
| March 31, 2026 | 1.326 |
| December 31, 2025 | 1.548 |
| September 30, 2025 | 2.355 |
| June 30, 2025 | 2.004 |
| March 31, 2025 | 1.763 |
| December 31, 2024 | 1.752 |
| September 30, 2024 | 1.038 |
| June 30, 2024 | 1.213 |
| March 31, 2024 | 1.196 |
| December 31, 2023 | 0.948 |
| September 30, 2023 | 0.9294 |
| June 30, 2023 | 0.9933 |
| March 31, 2023 | 1.107 |
| December 31, 2022 | 1.167 |
| September 30, 2022 | 1.213 |
| June 30, 2022 | 0.8961 |
| March 31, 2022 | 0.5613 |
| December 31, 2021 | 0.724 |
| September 30, 2021 | 0.6979 |
| June 30, 2021 | 0.6106 |
| March 31, 2021 | 1.294 |
| December 31, 2020 | 1.085 |
| September 30, 2020 | 1.281 |
| June 30, 2020 | 1.278 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.54 |
| December 31, 2019 | 0.4975 |
| September 30, 2019 | 0.367 |
| June 30, 2019 | 0.2887 |
| March 31, 2019 | 0.3357 |
| December 31, 2018 | 0.3707 |
| September 30, 2018 | 0.3653 |
| June 30, 2018 | 0.3188 |
| March 31, 2018 | 0.3248 |
| December 31, 2017 | 0.2757 |
| September 30, 2017 | 0.2729 |
| June 30, 2017 | 0.3202 |
| March 31, 2017 | 0.2882 |
| December 31, 2016 | 0.2817 |
| September 30, 2016 | 0.179 |
| June 30, 2016 | 0.1674 |
| March 31, 2016 | 0.1301 |
| December 31, 2015 | 0.1878 |
| September 30, 2015 | 0.1132 |
| June 30, 2015 | 0.1283 |
| March 31, 2015 | 0.1158 |
| December 31, 2014 | 0.0932 |
| September 30, 2014 | 0.0942 |
| June 30, 2014 | 0.0466 |
| March 31, 2014 | 0.0464 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AbbVie, Inc. | 3.537 |
| Ascendis Pharma A/S | 13.12 |
| Zealand Pharma A/S | 5.999 |
| Bavarian Nordic A/S | 1.041 |
| Evaxion AS | -1.054 |